Top 10 HealthCare Devices and Supplies Capital Raises and Investors in the U.S. – July 16th – August 31st, 2025
Several interesting transactions closed in the HealthCare Devices and Supplies sector over the past month. If you would like more info on these deals or would like to discuss the capital raising market for your company, please contact me.
Buyout/LBO
- BlueBin, supply chain management services that deliver supplies to clinicians and hospitals, acquired by Capsa Healthcare.
- HistoSonics, a non-invasive and robotically assisted ultrasound therapy device that enables precise tissue destruction, acquired by Johnson & Johnson Innovation – JJDC, Yonjin Venture, Alpha Wave Global, HealthQuest Capital, K5 Global, Lumira Ventures, Venture Investors, Hatteras Venture Partners, Early Stage Partners, Amzak Health, Alpha JWC Ventures, State of Michigan Retirement Systems, State of Wisconsin Investment Board, Bezos Expeditions and Wellington Management and its management through an LBO for $2.25 billion.
- PainTEQ, joint implants and interventional pain management procedures that treat back pain and sacroiliac fusion, acquired by Signet Healthcare Partners, Windham Capital Partners and MVolution Partners through an LBO.
- Velocity Medtech, sterilization cases and trays that support orthopedic surgical instruments and implants, acquired by Straits Orthopaedics.
Early Stage VC
- Moonrise Medical, an artificial intelligence-enabled ultrasound technology that serves the healthcare sector, raised venture funding from Providence Health Care Ventures and Government of Ontario.
- Apreo Health, investigational medical devices that treat severe emphysema by reducing lung hyperinflation, raised $130 million of Series B venture funding in a deal led by Bain Capital Life Sciences.
Accelerator/Incubator
- Bionic Power, lower-body smart orthoses that improve quality of life by enhancing personal mobility and walking abilities, joined MaRS Discovery District.
- CaviSense, a diagnostic tool that enables early-stage dental cavity detection, joined The Engine as a part of its Resident Companies.
Angel (individual)
- Operating Room Innovations, surgical equipment that delivers patient outcomes, workflow efficiencies, and operating room budgets, raised $17,553 of angel funding.
- Rhinal Therapeutics, nasal device technology that enables intranasal dry powder GLP-1 treatment, raised $20,000 of angel funding.
#castleplacement #capitalraising #privateequity #venturecapital #investment #healthcaredevicesandsupplies #healthcaredevice #healthcaresupplies
Tamara Williams
Managing Director
15+ years of experience in investment banking and financial structuring including private equity, acquisitions, fund management and raising debt capital within various sectors including real estate, oil and gas, hospitality, serviced offices, IT and trading. Advised on investment opportunities, capital structure, holding and tax structure. Skilled at conducting due diligence, company valuation and providing real estate development project oversight. International network extending from the US, UK, France, Russia, and the Middle East to Asia. Previously held several senior management positions in the financial industry. Master of Business Administration with Distinction from the University of Northampton UK. Higher National Diploma with Distinction from ABE UK. FINRA Series 7, 79, and 66 licenses.
- twilliams@castleplacement.com
- (385) 600-1871
 Tamara WilliamsManaging Director |
Please contact me if you have any questions or would like to discuss your capital raise:
Email: twilliams@castleplacement.com
(C) (385) 600-1871
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement® does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
